A Study of STRO4 in Patients Amyotrophic Lateral Sclerosis (ALS)

Clinical trial NCT06910384 · TERMINATED

Trial details

NCT number: NCT06910384
Sponsor: New England Cell Therapeutics, Inc.
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Amyotrophic Lateral Sclerosis

Start date: 2025-08-12
Primary completion: 2025-12-16
Enrollment: 1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.